
Product Description
PureCol®-S collagen is provided as a standard for use in assays where ultra-pure collagen is required.PureCol®-S collagen standard is approximately 97% Type I collagen with the remainder being comprised of Type III collagen. It contains a high monomer content as measured by gel permeation chromatography. This product is supplied at approximately a 3 mg/ml concentration. The concentration is confirmed by Biuret protein determination assay. The concentration for each specific lot is provided on a Certificate of Analysis that is available with the purchase of each product.PureCol®-Sis soluble atelo-collagen in 0.01 N HCI, therefore, the pH is approximately 2.0.
PureCol®-S is ideal for using as a collagen standard in controlled testing and assay procedures.PureCol®-Sis sterile filtered and is supplied as a ready to use solution.
Parameter, Testing, and Method | PureCol®-S Collagen Standard #5015 |
Sterilization Method | Filtration |
Extraction Method | Enzyme - atelocollagen |
Form | Solution |
Package Size | 20 mL |
Storage Temperature | 2-10°C |
Shelf Life | Minimum of 6 months from date of receipt |
Collagen Concentration - Biuret | 2.9-3.2 mg/mL |
Collagen Concentration - AAA | 2.9-3.2 mg/mL |
Collagen Purity - Silver Staining | >99.9% |
pH | 1.9-2.1 |
Kinetic Gel Test (Minutes) | <40 |
Gel Formation Tube Test (Minutes) | <40 |
Fibrillogenesis(Absorbance Units) | >0.5 |
Electrophoretic Pattern - Coomassie Blue | Characteristic |
Sterility - USP modified | No growth |
Endotoxin -LAL | <1.0 EU/mL |
Osmolality (mOsmo H2O/kg) | <35 |
Source | Bovine Hide |
Hydrogel Young's Modulus E (Pa) | Characteristic |
Directions for Use
Download the full PDF versionor continue reading below:
Coating Procedure
Note: Use these recommendations as guidelines to determine the optimal coating conditions for your culture system.
- Remove required quantity of collagen from the bottle and dispense into a dilution vessel.
- Dilute PureCol®-S in water to ~50 to 100 µg/ml (~1:30). A 0.01 N HCl solution may also be used.
- Swirl contents gently until material is completely mixed.
- Add appropriate amount of diluted PureCol®-S material to the culture surface ensuring that the entire surface is coated.
- Incubate at room temperature, covered, for 1-2 hours. Aspirate any remaining material. Alternatively, incubate at room temperature until surface is dry.
- Rinse coated surfaces carefully with sterile medium or PBS, avoid scratching surfaces.
- Coated surfaces are ready for use. They may also be stored at 2-8°C damp or air dried if sterility is maintained.
3-D Gel Preparation Procedure
- Slowly add 1 part of chilled 10X PBS or 10X culture media to 8 parts of chilled collagen solution with gentle swirling.
- Adjust pH of mixture to 7.2–7.6 using sterile 0.1 M NaOH. Monitor pH adjustment carefully (pH meter, phenol red, or pH paper).
- Adjust final volume to a total of 10 parts with sterile water.
- To prevent gelation, maintain temperature of mixture at 2–10°C.
- To form gel, warm to 37°C. Allow approximately 90 to 120 minutes for gel formation.
Product Q & A
The purity of PureCol® collagen is determined by SDS-PAGE, sodium dodecyl sulfate polyacrylamide gel electrophoresis in conjunction with bacterial collagenase sensitivity and silver staining techniques with a method sensitivity of 99.9%. It was found that PureCol® collagen is 95 to 98% Type I collagen and the remainder being comprised of Type III collagen.
SDS polyacrylamide gel electrophoresis demonstrates the presence of alpha, beta and gamma components in an appropriate ratio of approximately 40:30:30, respectively. PureCol® collagen is a native collagen as judged by polarimetry and trypsin sensitivity although the product does contain a low percentage of collagen fragments or shortened helices.
Conclusion: With the test method sensitivity of 99.9% (SDS-PAGE gel electrophoresis in conjunction with bacterial collagenase sensitivity and silver staining techniques) and no other proteins present in the preparation, it can be concluded that the purity of the PureCol® collagen is 99.9%.
The viscosity of PureCol® is ~32 cp.
PureCol® product has an isoelectric zone instead of isoelectric point. The isoelectric zone is pH 7 to 8. In addition, the collagen molecules in the PureCol® product will come out ofsolution starting at a pH above 5.5 and reach its plateau at pH 7 to 8 then gradually tapering off at pH 8 to 9.5.
Reduction of a commercially available, pepsin-solubilized, bovine dermal collagen (Vitrogen 100) (PureCol’s old product name) with sodium [3H]borohydride provided radiolabeled collagen preparations with specific activities ranging from 7.1-12.0 muCi/mg collagen. These specific activities were 2-3 times greater than those obtained by reduction of intact rat tail tendon collagen under similar conditions.
The alpha, beta, and higher aggregate components of type I collagen were radiolabeled as well as the alpha component of a small amount of type III collagen present in the samples. Fractionation of cyanogen bromide peptides showed that alpha 1(I)CB7, alpha 1(I)CB8, and alpha 2(I)CB3,5 were the predominant peptides labeled by this procedure. Amino acid analysis indicated that the majority of the radioactivity was in reducible cross-links, precursors of these cross-links, and in hexosyllysine residues.
Reconstitution experiments comparing this radiolabeled collagen with nonlabeled collagen showed them to be indistinguishable. Bacterial collagenase digestion of this reconstituted fibrillar collagen in both a lightly cross-linked (glutaraldehyde 0.0075%) and noncross-linked form provided evidence that digestion of labeled and nonlabeled collagens proceeded at similar rates. Thus, labeling did not change the properties of the collagen. Cross-linking made the preparation refractory to proteolytic degradation. Injection of fibrillar collagen preparations, spiked with radiolabeled collagen, into the guinea pig dermis followed by quantitation of the amount of radioactivity recovered from implant sites as a function of time, indicated that the lightly cross-linked samples also were more resistant to degradation in vivo than the noncross-linked preparation.
The half-life of noncross-linked collagen was about 4 days while that of the cross-linked collagen was about 25 days. These degradation rates were much faster than observed for similar, nonlabeled samples injected into the dermis of humans, presumably due to a higher metabolic activity in the guinea pig dermis.
Since the collagen in PureCol collagen contains approximately 95% Type I bovine collagen and 5% Type III bovine collagen, an anti-bovine collagen Type I antibody for your study can be used.
There is no difference. Vitrogen was the old tradename, and PureCol®is the new tradename.
We completed a study to show that DNA is completely destroyed at pH 2, and demonstrated that our collagen products do not contain DNA.
The collagen is fully hydrolyzed. The amino acid analysis is done using the Waters AccQ-Tag derivatization method.During the acid hydrolysis step, asparagine (N) is converted to aspartic acid (D) and glutamine (Q) is converted to glutamic acid (E). Tryptophan (W), if present, is destroyed during acid hydrolysis. Experimentally, one can determine the picomoles (pmol) of each amino acid per injected detected using amino acid standards.For the concentration determination, the total number of pmol of each amino acid is summed to get the total pmol of the 18 amino acids detected. The total pmol amino acids is divided by the theoretical number of amino acid residues in collagen based on the published sequence. The result is the pmol of collagen injected. The result is then multiplied by the dilution and 300,000 is used as the collagen molecular weight to get to mg/mL. The molecular weight of collagen is not well agreed upon.
Diluting with 1X PBS (rather than water or 0.01 N HCl) would have an effect for coating purposes. It would change the pH of the diluted collagen solution from acid to neutral pH. The pH change will transform the collagen molecules from a molecular form to a fibrillar form; and then the nature of coating surface will be changed from a monomeric coating to a fibrillar coating.
We use thefollowing antibodies from SouthernBiotech:
1. 1310-02 – Goat Anti-Type I Collagen-FITC
2. 1310-08 – Goat Anti-Type I Collagen-BIOT
3. 7100-05 – Streptavidin-HRP
The major collagen molecular species in our Type I collagen products are monomers (approx. 70%), but there are dimers, trimers and a few percentages of oligomers too (approx. 30%) with some minor amounts of collagen fragments. The collagen monomer is a rod shaped molecule with 300 nm in length and 1.5 nm in diameter. The dimer, trimer and oligomer are 600 nm, 900nm and even longer in length respectively. According to the coating procedures, the collagen molecules are attached to the charged polystyrene surface randomly by charge or affinity in acid conditions during the 1-2 hrs incubation period at 37°C, and any unattached materials are removed by aspiration and rinsing. Therefore, the coated surface is a single layer of collagen monomer, dimer, trimer and oligomer mixtures.The thickness of the mono-molecular layer is dependent on how those molecules are attached on the surface. The coating density thickness would generally be characterized as a 1 molecule thickness which could be ranging from a few nanometers to a few hundred nanometers with the whole surface being covered by collagen.
The net charge of Type I collagen products’ (PureCol®, Bovine Collagen and VitroCol®, Human Collagen) molecule is directly related to the pH. At an acidic pH, the amino acids (zwitterions) along the collagen molecule are positively charged, making the entire collagen molecule positive. At the isoelectric point (or zone) of collagen, around pH 7-8, the amino acids along the collagen molecule are positively and negatively charged, making the net charge of the collagen molecule close to zero. At a basic pH, the amino acids along the collagen molecule were negatively charged, making the entire collagen molecule negative.
Further, the nature of the charge of the collagen coating surface will be dependent on the type of coating applied. For a monomeric collagen coatings when the collagen is applied under an acidic pH condition, the surface is positively charged. If the surface is rinsed with pH neutral buffer or media then it will change the charge of the collagen surface net charge close to zero. For a 3D gel coating, the collagen prepared under neutral pH; the net charge of the collagen surface is close to zero.
Using rotary shadowing technique under transmission electron microscopy, it was found that our collagen, on average, consists of approximately 80% monomers, 13% dimers, trimers, and oligomers with the remaining 7% collagen fragments.
Yes.The collagen molecule in PureCol, Nutragen, VitroCol, and all of our other Atelo collagen products were prepared from native collagen matrix by pepsin treatment under controlled conditions to remove the non-helical portion, telo-peptides, only and the helical portion is intact. In this case, the enzymatic active sites for MMP (Matrix Metalloproteinase), such as for Mammalian Collagenase Matrix Metalloproteinase 8 (MMP-8), on the molecule was preserved.
These pepsin treated collagen products should behave as native intact collagen.
TGF beta would have been digested with the pepsin enzymatic digestion step. It was undetectable by SDS PAGE silver stain as well. We didn’t do any specific measurements by ELISA however but presences of TGF betais not anticipated.
We primarily use the Biuret method, but we also use BCA, AAA, and hydroxyl-proline assays.
- Collagen solutions that are frozen tend to have issues forming 3D hydrogels, and will likely not work. The solutions should still be good for 2D coatings.
- Collagen solutions that are left out at room temperature for extended periods of time may show signs of degradation, which will affect the formation of 3D hydrogels. It is likely still fine for 2D coatings.
Our recommendation is this: If you are using the product directly for a publication, we highly suggest buying a new bottle if the one you have was compromised.
Product References
Because PureCol® has been cited in over 2000 publications, we have only posted a few below:
Sorensen, Jacob R., et al. "An altered response in macrophage phenotype following damage in aged human skeletal muscle: implications for skeletal muscle repair."The FASEB Journal(2019): fj-201900519R.
Sorensen, Jacob R., et al. "An altered response in macrophage phenotype following damage in aged human skeletal muscle: implications for skeletal muscle repair."The FASEB Journal(2019): fj-201900519R.
Colaço, E., et al. "Hierarchical Collagen-Hydroxyapatite Nanostructures Designed Through Layer-by-Layer Assembly of Crystal-Decorated Fibrils."J., Hierarchical Collagen-Hydroxyapatite Nanostructures Designed Through Layer-by-Layer Assembly of Crystal-Decorated Fibrils (May 13, 2019)(2019).
Schwerdtfeger, Luke A., et al. "Human colon function ex vivo: Dependence on oxygen and sensitivity to antibiotic."PloS one14.5 (2019): e0217170.
Cardoso, Ana, et al. "MiR-144 overexpression as a promising therapeutic strategy to overcome glioblastoma cell invasiveness and resistance to chemotherapy."Human molecular genetics(2019).
Steele, Hannah E., et al. "Mechanotransduction of mitochondrial AMPK and its distinct role in flow-induced breast cancer cell migration."Biochemical and biophysical research communications514.2 (2019): 524-529.
Gehwolf, Renate, et al. "Global Responses of Il-1β-Primed 3D Tendon Constructs to Treatment with Pulsed Electromagnetic Fields."Cells8.5 (2019): 399.
Alexander, Frank, Sebastian Eggert, and Dorielle Price. "Label-Free Monitoring of 3D Tissue Models via Electrical Impedance Spectroscopy." (2019): 1-24.
Matysik-Woźniak, Anna, et al. "Examination of Kynurenine Toxicity on Corneal and Conjunctival Epithelium: In vitro and in vivo Studies."Ophthalmic research(2019): 1-12.
Compton, Clayton, et al. "Reconstitution of the Ventricular Endocardium Within Acellular Hearts."Regenerative Engineering and Translational Medicine(2019): 1-11.
Müller, A. L., et al. "4. Identification of miR-301a in Primary Human Atrial Fibroblasts and Bone Marrow-Derived Mesenchymal Progenitor Cells to Attenuate Endogenous Differentiation into Pro-Fibrotic Cells."Differentiation of Primary Human Pro-Fibrotic Mesenchymal Cells Influenced by Extracellular Matrix Environment Determined by Micro-RNA Expression(2018): 130.
Doblinger, Nina, et al. "Impact of hydroxyethyl starch and modified fluid gelatin on granulocyte phenotype and function."Transfusion(2019).
Elisabeth, et al. "Pro-Inflammatory Responses in Human Bronchial Epithelial Cells Induced by Spores and Hyphal Fragments of Common Damp Indoor Molds."International journal of environmental research and public health16.6 (2019): 1085.
Dodmane, Puttappa R., et al. "Biphasic changes in airway epithelial cell EGF receptor binding and phosphorylation induced by components of hogbarn dust."Experimental lung research44.10 (2018): 443-454.
McClellan, Alyce, et al. "A novel mechanism for the protection of embryonic stem cell derived tenocytes from inflammatory cytokine interleukin 1 beta."Scientific reports9 (2019).
Wang, Weiling, et al. "Aquaporin-3 deficiency slows cyst enlargement in experimental mouse models of autosomal dominant polycystic kidney disease."The FASEB Journal(2019): fj-201801338RRR.
Teo, Jye Yng, et al. "Surface tethering of stem cells with H2O2-responsive anti-oxidizing colloidal particles for protection against oxidation-induced death."Biomaterials201 (2019): 1-15.
Gehwolf, Renate, et al. "3D-Embedded Cell Cultures to Study Tendon Biology." (2019): 1-11.
Product Certificate of Analysis
Product Videos

How to Make 3D Collagen Hydrogels
Video

Seeding Collagen Gels with Cells
Video

30+ Type I Collagen Options
Video

Coating a Glass Coverslip with Collagen
Video
See More
Safety and Documentation
Safety Data Sheet
Certificate of Origin
Declaration of Material Source
Product Disclaimer
This product is for R&D use only and is not intended for human or other uses. Please consult the Material Safety Data Sheet for information regarding hazards and safe handling practices.
美国AdvancedBioMatrix(简称ABM) www.advancedbiomatrix.comAdvancedBioMatrix(简称ABM)是美国一家著名的生物公司,获得了AllerganInc的授权(Allergan用25年时间不断完善胶原蛋白相关的产品的生产工艺),将Allergan的专业和技术用于蛋白生产与检测,致力于为组织工程、细胞分析及细胞增殖等研究领域提供优质稳定的产品。AdvancedBioMatrix不断丰富已有产品线,目前可为三维细胞培养提供各种胶原蛋白、纤连蛋白、玻连蛋白、水性凝胶、不同粘度与分子量的透明质酸以及低代成纤维细胞等。在美国全部产品授权Sigma销售。AdvancedBioMatrix是组织培养,细胞分析和细胞增殖三维(3D)应用的生命科学领域的领导者。我们的产品被公认为纯度,功能性和一致性的标准。我们在生产,分离,纯化,冷冻干燥,细胞培养和蛋白质测试,粘附肽,附着因子,底物刚性和其他3D矩阵产品方面拥有丰富的专业知识。我们的专业技术和知识正在被用来确保我们的产品质量最高,批次之间一致且易于为我们的研究客户使用。
美国AdvancedBioMatrix是3D组织培养、细胞检测和细胞增殖等领域实验解决方案的佼佼者。AdvancedBioMatrix在分离、纯化、冻干、细胞培养和蛋白检测、多肽粘附、附着因子、基质硬度和其他3Dmatrix 产品开发方面有着丰富的经验。AdvancedBioMatrix的研发经验和专业知识确保其产品可达到最佳质量,并保证产品之间一致性,方便研究客户使用。以下为AdvancedBioMatrix3DMatrices 产品竞争优势:1. 提供高纯度和成分确定的胞外基质;2. 超过1000余篇文献引用PureCol产品,品质非常均一;3. 在3D培养基领域可提供最全面的产品线;4. 唯一可提供特异性刚性有机硅基板的公司(CytoSoft);5. 唯一可提供可溶性丝纤蛋白的供应商(可运用于多种3D培养);6. 如果客户首次接触3D胶原凝胶,AdvancedBioMatrix还是唯一的预制胶原蛋白(PureColEZGel)供应商;
以下产品为AdvancedBioMatrix全球畅销品:1.PureCol 牛源I型胶原蛋白 3mg/ml#5005-100ML2.Nutragen牛源I型胶原蛋白 6mg/ml#5010-50ML3.FibriCol 牛源I型胶原蛋白 10mg/ml#5133-20ML4.VitroCol 人源I型胶原蛋白 #5007-20ML5. 弹性蛋白原 #5052-1MG6.ECMSelectArraykitUltra-36#5170-1EA7.CytoSoft(刚性可变的基底,AdvancedBioMatrix最新添加产品5190-7EA)8. 人III型胶原蛋白 #5021-10MG9. 人IV型胶原蛋白 #5022-5MG10.SilkFibroin溶液 #5154-20ML11.Fibronectin#5080-5MG12.Vitronectin#5051-0.1MG
ebiomall.com






>
>
>
>
>
>
>
>
>
>
>
>
我们一般是在心导管室内,要在特殊的X线设备,可以转动的C臂心血管造影机,影像增强设备和电视荧屏设备,多导电生理记录仪,心脏程控刺激仪等。高档可以有三维电解剖生理定位标测系统比如CARTO,EnSite3000,这仅仅国内少数顶尖医院才有。
我们做电生理检查是通过你自身的血管放入心导管,直到心脏相应部位,一般主要局部麻醉,小孩则需要全麻。手术前必须停用抗心律失常药物至少5个半衰期以上,一般至少要3天,一般抗凝药物也是需要停用的。
我们局部需要手术前备皮,也就是局部皮肤清洁,有毛发的也需要清理干净。然后铺上洞巾。仅仅暴露局部血管穿刺部位。
我们穿刺血管插入诱发电极导管是根据不同需要来的,比如通常我们需要至少放置冠状静脉窦电极,右心室电极,高位右心房电极,和His束电极,那么冠状静脉窦电极是一般通过左锁骨下静脉或者右颈内静脉穿刺放置的,而右心室、高右房和His束电极则通过右股静脉放置。这些和体表心电图构成都可以让医生在电视屏幕上看到你不同的心电图图形,这样可以更加明确你心律失常的机制,部位。那么我们就可以标定你需要消融的部位(靶点)
我们通过插入电极导管,然后我们就进行心电生理检查,也就是人工给与各种电刺激,诱发你心律失常,比如我们可以采用输出电刺激信号比如用S1S1 刺激,也可以采用S1S2刺激等等,有时候可以静脉点滴异丙肾上腺素等药物,增加诱发的成功率,术前我们停用抗心律失常药物也是这个目的,就是诱发出你心律失常,这样我们根据体表和心内心电图,可以准确判断并定位你心律失常发生机制和部位,为下一步射频导管消融作准备,其实标定,是最为关键的一步,你只有找准敌人才能准确打击。准确的标定,也就是找准敌人的位置,那么就为打击敌人,做出关键的作用。我们的射频导管就像导弹一样,但是你必须先直到敌人在哪里,把它标定好,然后我们的导弹就可以直接定点清除。
目前比较新的高档的比如CARTO,就是类似于全球定位系统GPS的原理,可以准确三维立体定位你心律失常形成的部位和路径。一般我们针对最多是折返造成的心律失常,比如最多用于房室结双径路或者房室旁路引起的阵发性室上速,成功率一般是95%以上。
如果是房扑,主要是经典房扑,那么一般我们需要用一个Halo导管,一根可以弯折的上面带有很多对电极的导管,沿着折返环,环形放置。那么成功率也可以到95%。
首先导管插入部位(腹股沟、手臂、肩膀或颈部)的皮肤消毒,局麻药进行局部麻醉;然后用穿刺针穿刺静脉/动脉血管,电生理检查导管通过血管插入心腔;心脏电生理检查所用的电极导管长而可弯的导管,能将电信号传入和传出心脏。电极导管记录心脏不同部位的电活动,并发放微弱的电刺激来刺激心脏,以便诱发心律失常,明确心动过速诊断;然后医生通过导管找到心脏异常电活动的确切部位(此过程称为“标测”),再通过消融仪发送射频电流消融治疗,从而根治心动过速。 血管穿刺并发症包括局部出血、血肿、感染、气胸、血栓形成、栓塞等,导管操作并发症包括主动脉瓣返流、心肌穿孔、心包填塞等,放电消融并发症包括房室传导阻滞、心肌梗死等。向左转|向右转
我现在手头上有“医疗器械分类规则(局令第15号)”单位没有说ⅠⅡⅢ类的事情?请教!
唉,我去成都军区总医院问了,那没这种手术的设备`````````
希望能有知道的人解答一下
磁共振 CT 脑电图 多普勒 肌电图 诱发电位 脑脊液检查 血液检查。。。。。。。。。。。。
心内科
心脏电生理记录系统、有创血压监测系统、心脏射频消融仪、心电分析系统、多参数监护仪、医疗网络产品等。
产品主要用于心脏射频消融、心脏电生理检查、冠脉造影、经皮冠状动脉成型术、支架植入、二尖瓣球囊扩张等心脏介入手术;人体生理参数监测;心电图分析等

